Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Ultra Clean Holdings, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on May 23, 2025 [1]. Group 1: Class Action Details - Investors who purchased Ultra Clean securities between May 6, 2024, and February 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Ultra Clean misrepresented the demand for its products in the Chinese market, leading to investor damages when the true situation was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4].

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO” or the “Offering”). If you wish to serve as lead plaintiff, you must move th ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased enCore Energy Corp. securities between March 28, 2024, and March 2, 2025, of the May 13, 2025, deadline to become lead plaintiffs in a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought enCore securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by May 13, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that enCore made false or misleading statements and failed to disclose significant issues regarding its internal controls and financial reporting, leading to increased net losses [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [3]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Maravai Lifesciences Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on May 5, 2025 [1]. Group 1: Class Action Details - Investors who purchased Maravai securities between August 7, 2024, and February 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Maravai made false or misleading statements regarding its financial reporting and internal controls, leading to inaccurate revenue recognition and overstated goodwill [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Viatris Inc. securities between August 8, 2024, and February 26, 2025, of the June 3, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Viatris securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by June 3, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Viatris provided misleading information regarding the failed inspection of its Indore, India facility, including the impact of an FDA Warning Letter that restricted shipments of eleven products [4][5] Group 2: Misleading Statements - Defendants allegedly made materially false statements and concealed adverse facts about the financial impact of the FDA Warning Letter on Viatris [5] - The lawsuit claims that the lack of disclosure regarding the inspection timeline, remediation efforts, and the financial implications led to investors purchasing securities at artificially inflated prices [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [3]

Core Viewpoint - A class action lawsuit has been filed against Firsthand Technology Value Fund, Inc. for alleged misleading statements and actions that resulted in significant shareholder losses during the Class Period from January 1, 2021, to November 14, 2023 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that the Fund's managers destroyed over $200 million in shareholder value and inflated the value of remaining investments using implausible valuation methodologies [5]. - It is alleged that these fraudulent valuations were incorporated into the Fund's publicly stated net asset value (NAV), misleading investors about the true value of their shares [5]. - As a result of these actions, purchasers of the Fund's shares during the Class Period experienced significant inflation in market price due to the fraudulent NAVs [5]. Group 2: Participation Information - Shareholders who purchased Firsthand Technology securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm for more information [3][6]. - A lead plaintiff must file a motion with the Court by May 20, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

Core Viewpoint - A class action lawsuit has been filed against BigBear.ai Holdings, Inc. for alleged misleading statements and accounting errors during the Class Period from March 31, 2022, to March 25, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that BigBear.ai made false and misleading statements regarding its accounting practices, particularly related to the 2026 Convertible Notes [5]. - Specific allegations include deficiencies in accounting review policies and improper accounting for the conversion option within the 2026 Convertible Notes, which led to misstated financial statements [5]. - The lawsuit asserts that these inaccuracies would likely require restatements of financial statements and could delay filings with the SEC, causing investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased BigBear.ai securities during the Class Period may be entitled to compensation without upfront costs through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by June 10, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its success in securities class action settlements and has a history of representing investors globally [4].

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Bancorp, Inc. (NASDAQ: TBBK) between January 25, 2024 and March 4, 2025, both dates inclusive (the “Class Period”), of the important May 16, 2025 lead plaintiff deadline. SO WHAT: If you purchased Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Atkore Inc. common stock between August 2, 2022, and February 3, 2025, of the April 23, 2025, deadline to become a lead plaintiff in a class action lawsuit related to alleged misleading statements and anticompetitive practices by Atkore [1][4]. Group 1: Class Action Details - Investors who bought Atkore common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by April 23, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that Atkore engaged in a price-fixing scheme that artificially inflated the prices of PVC pipes, leading to significant financial benefits that were unsustainable [4]. Group 2: Allegations Against Atkore - The lawsuit claims that Atkore's price-fixing scheme was exposed, resulting in a substantial decrease in the price of PVC pipes and negatively impacting the company's business and operations [4]. - Defendants allegedly made false and misleading statements regarding Atkore's business prospects, which lacked a reasonable basis during the Class Period [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3].